Brain tumor center launches new clinical trial for recurrent glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a new Phase 0 clinical trial to evaluate two targeted therapy drugs, abemaciclib and LY3214996. The study will ...
May 27, 2020
0
0